

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 7.01540719 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 6.60289153 |
| 3 | intestinal cholesterol absorption (GO:0030299) | 6.51545889 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.90976318 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.70252679 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.55982953 |
| 7 | negative T cell selection (GO:0043383) | 5.34580668 |
| 8 | regulation of guanylate cyclase activity (GO:0031282) | 5.25072664 |
| 9 | regulation of bile acid biosynthetic process (GO:0070857) | 5.24207914 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.22807652 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.22807652 |
| 12 | angiotensin maturation (GO:0002003) | 5.16508701 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 5.05255792 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.98313725 |
| 15 | response to interleukin-15 (GO:0070672) | 4.96533986 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.90700624 |
| 17 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.89682262 |
| 18 | positive T cell selection (GO:0043368) | 4.72624252 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.67949772 |
| 20 | drug metabolic process (GO:0017144) | 4.67702916 |
| 21 | NADH metabolic process (GO:0006734) | 4.67166829 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 4.65946910 |
| 23 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.64877319 |
| 24 | drug catabolic process (GO:0042737) | 4.54466722 |
| 25 | hormone catabolic process (GO:0042447) | 4.43203869 |
| 26 | lipoprotein transport (GO:0042953) | 4.43148826 |
| 27 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.43010020 |
| 28 | urea metabolic process (GO:0019627) | 4.40782339 |
| 29 | cellular glucuronidation (GO:0052695) | 4.40539826 |
| 30 | exogenous drug catabolic process (GO:0042738) | 4.31176659 |
| 31 | uronic acid metabolic process (GO:0006063) | 4.30864284 |
| 32 | glucuronate metabolic process (GO:0019585) | 4.30864284 |
| 33 | thymic T cell selection (GO:0045061) | 4.26949605 |
| 34 | T cell selection (GO:0045058) | 4.24797035 |
| 35 | urea cycle (GO:0000050) | 4.23113466 |
| 36 | diacylglycerol metabolic process (GO:0046339) | 4.21568418 |
| 37 | fructose metabolic process (GO:0006000) | 4.21397195 |
| 38 | T cell costimulation (GO:0031295) | 4.15513717 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.07030483 |
| 40 | regulation of cellular extravasation (GO:0002691) | 4.05765610 |
| 41 | lymphocyte costimulation (GO:0031294) | 4.05045288 |
| 42 | positive regulation of tolerance induction (GO:0002645) | 4.03602331 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.02682205 |
| 44 | negative regulation of cell killing (GO:0031342) | 4.02682205 |
| 45 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.00527534 |
| 46 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.00504755 |
| 47 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.99723446 |
| 48 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.88226137 |
| 49 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.85712487 |
| 50 | endocrine process (GO:0050886) | 3.85712487 |
| 51 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.85712487 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 3.85518492 |
| 53 | cellular response to interleukin-15 (GO:0071350) | 3.81907941 |
| 54 | complement activation, alternative pathway (GO:0006957) | 3.81618862 |
| 55 | regulation of protein activation cascade (GO:2000257) | 3.80960563 |
| 56 | complement activation, classical pathway (GO:0006958) | 3.79731436 |
| 57 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.77663552 |
| 58 | Peyers patch development (GO:0048541) | 3.77663552 |
| 59 | peptide hormone processing (GO:0016486) | 3.76753661 |
| 60 | bile acid and bile salt transport (GO:0015721) | 3.76585429 |
| 61 | regulation of complement activation (GO:0030449) | 3.76139681 |
| 62 | ethanol oxidation (GO:0006069) | 3.75637373 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 3.73832491 |
| 64 | macromolecular complex remodeling (GO:0034367) | 3.73832491 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 3.73832491 |
| 66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.71674099 |
| 67 | high-density lipoprotein particle remodeling (GO:0034375) | 3.70629726 |
| 68 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.68023021 |
| 69 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.67511788 |
| 70 | arginine metabolic process (GO:0006525) | 3.63255318 |
| 71 | alkaloid metabolic process (GO:0009820) | 3.62765932 |
| 72 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.62625417 |
| 73 | peptide catabolic process (GO:0043171) | 3.61278769 |
| 74 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.61191252 |
| 75 | interferon-gamma production (GO:0032609) | 3.58802084 |
| 76 | digestion (GO:0007586) | 3.57167273 |
| 77 | vitamin A metabolic process (GO:0006776) | 3.56771133 |
| 78 | T cell receptor signaling pathway (GO:0050852) | 3.56152191 |
| 79 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.55870061 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 3.53977327 |
| 81 | hepatocyte apoptotic process (GO:0097284) | 3.53879840 |
| 82 | bile acid metabolic process (GO:0008206) | 3.51296601 |
| 83 | plasma lipoprotein particle organization (GO:0071827) | 3.49262305 |
| 84 | positive regulation of interleukin-2 production (GO:0032743) | 3.46870008 |
| 85 | regulation of systemic arterial blood pressure (GO:0003073) | 3.44173572 |
| 86 | regulation of tolerance induction (GO:0002643) | 3.43764188 |
| 87 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.42871417 |
| 88 | complement activation (GO:0006956) | 3.38962231 |
| 89 | phenylpropanoid metabolic process (GO:0009698) | 3.38088020 |
| 90 | regulation of cGMP biosynthetic process (GO:0030826) | 3.37504732 |
| 91 | omega-hydroxylase P450 pathway (GO:0097267) | 3.37155617 |
| 92 | lipoprotein metabolic process (GO:0042157) | 3.37120571 |
| 93 | protein-lipid complex subunit organization (GO:0071825) | 3.30886338 |
| 94 | phospholipid scrambling (GO:0017121) | 3.30781854 |
| 95 | reverse cholesterol transport (GO:0043691) | 3.30282250 |
| 96 | dendritic cell chemotaxis (GO:0002407) | 3.29602527 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.27771451 |
| 98 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.27397630 |
| 99 | leukocyte aggregation (GO:0070486) | 3.26361629 |
| 100 | regulation of response to interferon-gamma (GO:0060330) | 3.25422734 |
| 101 | positive regulation of response to oxidative stress (GO:1902884) | 3.24916775 |
| 102 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.24916775 |
| 103 | cholesterol efflux (GO:0033344) | 3.24701330 |
| 104 | digestive system process (GO:0022600) | 3.23719260 |
| 105 | flavonoid metabolic process (GO:0009812) | 3.23067789 |
| 106 | glycolipid catabolic process (GO:0019377) | 3.22375206 |
| 107 | acute-phase response (GO:0006953) | 3.19280267 |
| 108 | regulation of histone H3-K27 methylation (GO:0061085) | 3.18505566 |
| 109 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.17555182 |
| 110 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16997881 |
| 111 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.15502204 |
| 112 | positive regulation of isotype switching (GO:0045830) | 3.14257800 |
| 113 | vitamin transport (GO:0051180) | 3.11791666 |
| 114 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.10484924 |
| 115 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.10120484 |
| 116 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.09259589 |
| 117 | glycosphingolipid catabolic process (GO:0046479) | 3.08186640 |
| 118 | protein activation cascade (GO:0072376) | 3.07806556 |
| 119 | antibacterial humoral response (GO:0019731) | 3.06037667 |
| 120 | low-density lipoprotein particle remodeling (GO:0034374) | 3.04373879 |
| 121 | antimicrobial humoral response (GO:0019730) | 3.03820740 |
| 122 | drug transport (GO:0015893) | 3.02832729 |
| 123 | regulation of extracellular matrix disassembly (GO:0010715) | 3.02696899 |
| 124 | regulation of cholesterol metabolic process (GO:0090181) | 3.02653838 |
| 125 | plasma lipoprotein particle assembly (GO:0034377) | 3.01798718 |
| 126 | trophectodermal cell differentiation (GO:0001829) | 3.00496393 |
| 127 | mature B cell differentiation (GO:0002335) | 3.00064828 |
| 128 | positive regulation of histone deacetylation (GO:0031065) | 2.97293081 |
| 129 | virion attachment to host cell (GO:0019062) | 2.95098946 |
| 130 | adhesion of symbiont to host cell (GO:0044650) | 2.95098946 |
| 131 | auditory receptor cell differentiation (GO:0042491) | 2.94466051 |
| 132 | T cell migration (GO:0072678) | 2.93808843 |
| 133 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.91929558 |
| 134 | dendritic cell migration (GO:0036336) | 2.91318535 |
| 135 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.91073500 |
| 136 | cholesterol homeostasis (GO:0042632) | 2.90828609 |
| 137 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.90688315 |
| 138 | negative regulation of cholesterol transport (GO:0032375) | 2.89689011 |
| 139 | negative regulation of sterol transport (GO:0032372) | 2.89689011 |
| 140 | drug transmembrane transport (GO:0006855) | 2.89487653 |
| 141 | angiogenesis involved in wound healing (GO:0060055) | 2.88577290 |
| 142 | ethanol metabolic process (GO:0006067) | 2.88387207 |
| 143 | regulation of regulatory T cell differentiation (GO:0045589) | 2.88152785 |
| 144 | positive regulation of pseudopodium assembly (GO:0031274) | 2.87867030 |
| 145 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86477486 |
| 146 | sterol homeostasis (GO:0055092) | 2.85394575 |
| 147 | T cell differentiation (GO:0030217) | 2.85153440 |
| 148 | protein-lipid complex assembly (GO:0065005) | 2.85068348 |
| 149 | purine nucleotide salvage (GO:0032261) | 2.84195049 |
| 150 | embryonic process involved in female pregnancy (GO:0060136) | 2.82978097 |
| 151 | regulation of fibrinolysis (GO:0051917) | 2.79975874 |
| 152 | L-ascorbic acid metabolic process (GO:0019852) | 2.79715607 |
| 153 | renal system process involved in regulation of blood volume (GO:0001977) | 2.79713900 |
| 154 | mature B cell differentiation involved in immune response (GO:0002313) | 2.79711831 |
| 155 | alpha-beta T cell activation (GO:0046631) | 2.79515004 |
| 156 | ganglioside metabolic process (GO:0001573) | 2.78661191 |
| 157 | positive regulation of respiratory burst (GO:0060267) | 2.78206781 |
| 158 | V(D)J recombination (GO:0033151) | 2.78020215 |
| 159 | leukocyte cell-cell adhesion (GO:0007159) | 2.77229839 |
| 160 | regulation of respiratory burst (GO:0060263) | 2.76798883 |
| 161 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.76250933 |
| 162 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.75666919 |
| 163 | response to hepatocyte growth factor (GO:0035728) | 2.75666919 |
| 164 | T cell activation (GO:0042110) | 2.74461004 |
| 165 | activated T cell proliferation (GO:0050798) | 2.73010335 |
| 166 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.72495912 |
| 167 | myoblast migration (GO:0051451) | 2.72263328 |
| 168 | positive regulation of DNA recombination (GO:0045911) | 2.71951462 |
| 169 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.71890163 |
| 170 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.71890163 |
| 171 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.71045323 |
| 172 | phospholipid efflux (GO:0033700) | 2.70608038 |
| 173 | regulation of isotype switching (GO:0045191) | 2.70127122 |
| 174 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69256346 |
| 175 | sialylation (GO:0097503) | 2.68744099 |
| 176 | sulfate transmembrane transport (GO:1902358) | 2.68701644 |
| 177 | actin filament depolymerization (GO:0030042) | 2.68274405 |
| 178 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.68134605 |
| 179 | B cell receptor signaling pathway (GO:0050853) | 2.67154635 |
| 180 | glycosphingolipid biosynthetic process (GO:0006688) | 2.66870428 |
| 181 | T cell homeostasis (GO:0043029) | 2.66776242 |
| 182 | epithelial structure maintenance (GO:0010669) | 2.63744056 |
| 183 | lymphocyte homeostasis (GO:0002260) | 2.59912655 |
| 184 | regulation of triglyceride catabolic process (GO:0010896) | 2.59726020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.19369040 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.81529192 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.62827480 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.10836654 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.65431427 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.33761601 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.12278419 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.10566971 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.09743609 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.08972646 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.86038001 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.85587095 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82349908 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.76037443 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72549647 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.70252451 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.69185794 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.68982592 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.62492919 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.48134765 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.48112931 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.47933296 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.37528731 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.34273890 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33569044 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.28007150 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26685580 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 2.25764798 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20808069 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.09484913 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07214993 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03857664 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01987086 |
| 34 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.93966956 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93367303 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.90111669 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87965628 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85357578 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82057026 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.77472821 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76062160 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.73651781 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72311134 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72075819 |
| 45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69265102 |
| 46 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.65006866 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63657254 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61625961 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.61061842 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59212143 |
| 51 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59010327 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58711546 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55939064 |
| 54 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.54925158 |
| 55 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54570021 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54475630 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54246589 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.53604990 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52901347 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52360632 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47039147 |
| 62 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.46866358 |
| 63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44893750 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44244417 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43980503 |
| 66 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.43755920 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43486615 |
| 68 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43465533 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43162787 |
| 70 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42354393 |
| 71 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41865265 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41787382 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38430940 |
| 74 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.37492474 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.36632701 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35855336 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34407119 |
| 78 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.33231073 |
| 79 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.33128513 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31619699 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30585609 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29629272 |
| 83 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.29420336 |
| 84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27648001 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24591328 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24400907 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23298061 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22188584 |
| 89 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.20587065 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18312156 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17816924 |
| 92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17211503 |
| 93 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15302955 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14985431 |
| 95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.13448024 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12003493 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10665164 |
| 98 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09812728 |
| 99 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09148102 |
| 100 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08722839 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08562296 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07889419 |
| 103 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07605655 |
| 104 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07581890 |
| 105 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06374285 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05233814 |
| 107 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04931651 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04373260 |
| 109 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03678152 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02711898 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02430455 |
| 112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02145079 |
| 113 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01260551 |
| 114 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00575869 |
| 115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99677810 |
| 116 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98950374 |
| 117 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98731881 |
| 118 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98323151 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98051367 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96626517 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96533680 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95935761 |
| 123 | P68_20966046_ChIP-Seq_HELA_Human | 0.95027571 |
| 124 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94701591 |
| 125 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94188386 |
| 126 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93964445 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93407676 |
| 128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93347282 |
| 129 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.93328421 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93221079 |
| 131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92706299 |
| 132 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91962911 |
| 133 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91562616 |
| 134 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90277662 |
| 135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89965750 |
| 136 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.88746993 |
| 137 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88499831 |
| 138 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88091594 |
| 139 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88081694 |
| 140 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.87572776 |
| 141 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86934600 |
| 142 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86865734 |
| 143 | P300_27268052_Chip-Seq_Bcells_Human | 0.86540672 |
| 144 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.85498313 |
| 145 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.84990860 |
| 146 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84317767 |
| 147 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.83304518 |
| 148 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83282140 |
| 149 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83262253 |
| 150 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83062418 |
| 151 | * ELF5_23300383_ChIP-Seq_T47D_Human | 0.82674545 |
| 152 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82353950 |
| 153 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.82214010 |
| 154 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.81918093 |
| 155 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81766619 |
| 156 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81576840 |
| 157 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81467367 |
| 158 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80047512 |
| 159 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.79972942 |
| 160 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.79901022 |
| 161 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79784119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.98224323 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.55089615 |
| 3 | MP0001666_abnormal_nutrient_absorption | 3.48355345 |
| 4 | MP0003866_abnormal_defecation | 3.15146202 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.09432783 |
| 6 | MP0010155_abnormal_intestine_physiology | 2.97083987 |
| 7 | MP0005671_abnormal_response_to | 2.92392656 |
| 8 | MP0000685_abnormal_immune_system | 2.90926106 |
| 9 | MP0001800_abnormal_humoral_immune | 2.85957645 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.69551728 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.62524952 |
| 12 | MP0009840_abnormal_foam_cell | 2.55293048 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.46905398 |
| 14 | MP0001873_stomach_inflammation | 2.46355966 |
| 15 | MP0005387_immune_system_phenotype | 2.37641340 |
| 16 | MP0001790_abnormal_immune_system | 2.37641340 |
| 17 | MP0004947_skin_inflammation | 2.26216655 |
| 18 | MP0002398_abnormal_bone_marrow | 2.25683821 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.23962666 |
| 20 | MP0000490_abnormal_crypts_of | 2.20809369 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.20321446 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.19402834 |
| 23 | MP0005332_abnormal_amino_acid | 2.19050443 |
| 24 | MP0001819_abnormal_immune_cell | 2.17942803 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 2.10825727 |
| 26 | MP0002723_abnormal_immune_serum | 2.10662535 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.99382661 |
| 28 | MP0000716_abnormal_immune_system | 1.98428614 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.94510961 |
| 30 | MP0003195_calcinosis | 1.91322968 |
| 31 | MP0000703_abnormal_thymus_morphology | 1.90813025 |
| 32 | MP0003868_abnormal_feces_composition | 1.90556946 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.88968411 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.88613685 |
| 35 | MP0005025_abnormal_response_to | 1.87964101 |
| 36 | MP0002722_abnormal_immune_system | 1.84853922 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.84369545 |
| 38 | MP0006082_CNS_inflammation | 1.83906287 |
| 39 | MP0002405_respiratory_system_inflammati | 1.83495060 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.82611797 |
| 41 | MP0002132_abnormal_respiratory_system | 1.77307785 |
| 42 | MP0002429_abnormal_blood_cell | 1.72439949 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.70980735 |
| 44 | MP0004147_increased_porphyrin_level | 1.69890719 |
| 45 | MP0006054_spinal_hemorrhage | 1.69651108 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.66795095 |
| 47 | MP0009785_altered_susceptibility_to | 1.65678189 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 1.60778718 |
| 49 | MP0005409_darkened_coat_color | 1.54531478 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.54099324 |
| 51 | MP0001764_abnormal_homeostasis | 1.52010727 |
| 52 | MP0001664_abnormal_digestion | 1.50895731 |
| 53 | MP0003252_abnormal_bile_duct | 1.48846533 |
| 54 | MP0003879_abnormal_hair_cell | 1.48342049 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.45528290 |
| 56 | MP0002006_tumorigenesis | 1.45271018 |
| 57 | MP0001663_abnormal_digestive_system | 1.44314902 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.43607931 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.43128571 |
| 60 | MP0003724_increased_susceptibility_to | 1.42636156 |
| 61 | MP0000462_abnormal_digestive_system | 1.42148403 |
| 62 | MP0000477_abnormal_intestine_morphology | 1.35884979 |
| 63 | MP0000678_abnormal_parathyroid_gland | 1.33451727 |
| 64 | MP0000858_altered_metastatic_potential | 1.31059651 |
| 65 | MP0005166_decreased_susceptibility_to | 1.29727112 |
| 66 | MP0003436_decreased_susceptibility_to | 1.27636980 |
| 67 | MP0005310_abnormal_salivary_gland | 1.24101075 |
| 68 | MP0001756_abnormal_urination | 1.22908892 |
| 69 | MP0005381_digestive/alimentary_phenotyp | 1.21419162 |
| 70 | MP0010329_abnormal_lipoprotein_level | 1.18831641 |
| 71 | MP0002419_abnormal_innate_immunity | 1.16987881 |
| 72 | MP0002009_preneoplasia | 1.16161250 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.14741559 |
| 74 | MP0005451_abnormal_body_composition | 1.14386853 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 1.12111296 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.09883893 |
| 77 | MP0002139_abnormal_hepatobiliary_system | 1.09401578 |
| 78 | MP0003045_fibrosis | 1.07779238 |
| 79 | MP0002971_abnormal_brown_adipose | 1.06006649 |
| 80 | MP0004858_abnormal_nervous_system | 1.05062232 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.99882993 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 0.99405318 |
| 83 | MP0000609_abnormal_liver_physiology | 0.98149146 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.96889737 |
| 85 | MP0002933_joint_inflammation | 0.96045492 |
| 86 | MP0000538_abnormal_urinary_bladder | 0.95463797 |
| 87 | MP0008961_abnormal_basal_metabolism | 0.94610756 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.94331977 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.94108862 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.93728663 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 0.91563567 |
| 92 | MP0005535_abnormal_body_temperature | 0.91321783 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90834418 |
| 94 | MP0002909_abnormal_adrenal_gland | 0.89967061 |
| 95 | MP0008469_abnormal_protein_level | 0.86236730 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.84709966 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.83670823 |
| 98 | MP0005076_abnormal_cell_differentiation | 0.82872813 |
| 99 | MP0004043_abnormal_pH_regulation | 0.81996222 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.81450878 |
| 101 | MP0002822_catalepsy | 0.81156105 |
| 102 | MP0008004_abnormal_stomach_pH | 0.79541481 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.78868770 |
| 104 | MP0000604_amyloidosis | 0.78058842 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 0.76983839 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.76088332 |
| 107 | MP0002693_abnormal_pancreas_physiology | 0.74752240 |
| 108 | MP0001851_eye_inflammation | 0.72577180 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.72569420 |
| 110 | MP0003953_abnormal_hormone_level | 0.71775853 |
| 111 | MP0005448_abnormal_energy_balance | 0.71081998 |
| 112 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70560598 |
| 113 | MP0004019_abnormal_vitamin_homeostasis | 0.69801418 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.69263116 |
| 115 | MP0005334_abnormal_fat_pad | 0.68283193 |
| 116 | MP0001849_ear_inflammation | 0.67634766 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.67250244 |
| 118 | MP0003448_altered_tumor_morphology | 0.67109994 |
| 119 | MP0002254_reproductive_system_inflammat | 0.66308030 |
| 120 | MP0003303_peritoneal_inflammation | 0.66055570 |
| 121 | MP0001485_abnormal_pinna_reflex | 0.66038460 |
| 122 | MP0005670_abnormal_white_adipose | 0.64719034 |
| 123 | MP0009115_abnormal_fat_cell | 0.63765818 |
| 124 | MP0001533_abnormal_skeleton_physiology | 0.63512351 |
| 125 | MP0003329_amyloid_beta_deposits | 0.63263501 |
| 126 | MP0001216_abnormal_epidermal_layer | 0.63090261 |
| 127 | MP0001853_heart_inflammation | 0.62463913 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.61622762 |
| 129 | MP0001881_abnormal_mammary_gland | 0.61310001 |
| 130 | MP0000598_abnormal_liver_morphology | 0.61015778 |
| 131 | MP0004957_abnormal_blastocyst_morpholog | 0.59316389 |
| 132 | MP0008872_abnormal_physiological_respon | 0.59174302 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.59045602 |
| 134 | MP0000249_abnormal_blood_vessel | 0.58923979 |
| 135 | MP0000537_abnormal_urethra_morphology | 0.58847280 |
| 136 | MP0002089_abnormal_postnatal_growth/wei | 0.57030835 |
| 137 | MP0005174_abnormal_tail_pigmentation | 0.56735100 |
| 138 | MP0005636_abnormal_mineral_homeostasis | 0.56471055 |
| 139 | MP0001944_abnormal_pancreas_morphology | 0.56137760 |
| 140 | MP0009764_decreased_sensitivity_to | 0.55390400 |
| 141 | MP0002796_impaired_skin_barrier | 0.55226887 |
| 142 | MP0005365_abnormal_bile_salt | 0.54211806 |
| 143 | MP0000566_synostosis | 0.53955580 |
| 144 | MP0001191_abnormal_skin_condition | 0.53526368 |
| 145 | MP0002998_abnormal_bone_remodeling | 0.53000668 |
| 146 | MP0003111_abnormal_nucleus_morphology | 0.52694255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune hemolytic anemia (HP:0001890) | 6.11129858 |
| 2 | B lymphocytopenia (HP:0010976) | 5.33755215 |
| 3 | Abnormality of B cell number (HP:0010975) | 5.33755215 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.26792128 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 5.08724779 |
| 6 | Acanthocytosis (HP:0001927) | 5.07810846 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 5.05145031 |
| 8 | T lymphocytopenia (HP:0005403) | 5.04185194 |
| 9 | Combined immunodeficiency (HP:0005387) | 4.94608301 |
| 10 | Abnormality of T cell number (HP:0011839) | 4.84507598 |
| 11 | Complement deficiency (HP:0004431) | 4.81610182 |
| 12 | Fat malabsorption (HP:0002630) | 4.72796213 |
| 13 | Pustule (HP:0200039) | 4.68297223 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.60068021 |
| 15 | Recurrent viral infections (HP:0004429) | 4.51275189 |
| 16 | Ileus (HP:0002595) | 4.46894744 |
| 17 | Nasal polyposis (HP:0100582) | 4.33419856 |
| 18 | Xanthomatosis (HP:0000991) | 4.25682864 |
| 19 | Abnormality of complement system (HP:0005339) | 4.20519066 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 4.03259413 |
| 21 | Thyroiditis (HP:0100646) | 3.98248966 |
| 22 | Abnormality of T cells (HP:0002843) | 3.94747148 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.84805443 |
| 24 | Chronic diarrhea (HP:0002028) | 3.79181467 |
| 25 | Recurrent bronchitis (HP:0002837) | 3.74079975 |
| 26 | Poikilocytosis (HP:0004447) | 3.71043597 |
| 27 | IgM deficiency (HP:0002850) | 3.65720860 |
| 28 | Steatorrhea (HP:0002570) | 3.64115557 |
| 29 | Glomerulonephritis (HP:0000099) | 3.61734885 |
| 30 | Abnormality of vitamin B metabolism (HP:0004340) | 3.57695081 |
| 31 | Eosinophilia (HP:0001880) | 3.57092561 |
| 32 | Recurrent sinusitis (HP:0011108) | 3.56815183 |
| 33 | Widely patent fontanelles and sutures (HP:0004492) | 3.51326814 |
| 34 | Hypobetalipoproteinemia (HP:0003563) | 3.44540069 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 3.43555218 |
| 36 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.42967842 |
| 37 | Abnormality of vitamin metabolism (HP:0100508) | 3.42741583 |
| 38 | Chronic otitis media (HP:0000389) | 3.34592875 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.31551838 |
| 40 | Abnormality of eosinophils (HP:0001879) | 3.30555501 |
| 41 | Agammaglobulinemia (HP:0004432) | 3.29687203 |
| 42 | Deep venous thrombosis (HP:0002625) | 3.27995259 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 3.25727286 |
| 44 | Glycosuria (HP:0003076) | 3.25727286 |
| 45 | Inflammation of the large intestine (HP:0002037) | 3.23968412 |
| 46 | Increased IgE level (HP:0003212) | 3.19470172 |
| 47 | Colitis (HP:0002583) | 3.12041018 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 3.06810269 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.05740945 |
| 50 | Granulocytopenia (HP:0001913) | 3.03613288 |
| 51 | Potter facies (HP:0002009) | 3.02076143 |
| 52 | Facial shape deformation (HP:0011334) | 3.02076143 |
| 53 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.01638080 |
| 54 | Congenital sensorineural hearing impairment (HP:0008527) | 2.99540060 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99247852 |
| 56 | Lymphopenia (HP:0001888) | 2.96495284 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.90830583 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.90338101 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.87627822 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.87172297 |
| 61 | Hyperglycinuria (HP:0003108) | 2.84811810 |
| 62 | Prolonged partial thromboplastin time (HP:0003645) | 2.84278633 |
| 63 | Proximal tubulopathy (HP:0000114) | 2.80211937 |
| 64 | IgG deficiency (HP:0004315) | 2.78983452 |
| 65 | Nephritis (HP:0000123) | 2.78958107 |
| 66 | Hypophosphatemia (HP:0002148) | 2.76057558 |
| 67 | Toxemia of pregnancy (HP:0100603) | 2.75537324 |
| 68 | Confusion (HP:0001289) | 2.75343144 |
| 69 | Alveolar cell carcinoma (HP:0006519) | 2.69947171 |
| 70 | Easy fatigability (HP:0003388) | 2.68253722 |
| 71 | Papilloma (HP:0012740) | 2.67875178 |
| 72 | Verrucae (HP:0200043) | 2.67875178 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.66759257 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.66759257 |
| 75 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.61735156 |
| 76 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.61615077 |
| 77 | Abnormality of glycine metabolism (HP:0010895) | 2.61615077 |
| 78 | Abnormality of the fingertips (HP:0001211) | 2.58950042 |
| 79 | Cheilitis (HP:0100825) | 2.55479704 |
| 80 | Volvulus (HP:0002580) | 2.54551997 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53566768 |
| 82 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.50190003 |
| 83 | Bronchiectasis (HP:0002110) | 2.50052606 |
| 84 | Intrahepatic cholestasis (HP:0001406) | 2.49804540 |
| 85 | Thin bony cortex (HP:0002753) | 2.47031010 |
| 86 | Villous atrophy (HP:0011473) | 2.46990360 |
| 87 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.46990360 |
| 88 | Hyperuricemia (HP:0002149) | 2.46167667 |
| 89 | Increased purine levels (HP:0004368) | 2.46167667 |
| 90 | Leukocytosis (HP:0001974) | 2.43135066 |
| 91 | Alkalosis (HP:0001948) | 2.43108408 |
| 92 | Epidermoid cyst (HP:0200040) | 2.39137548 |
| 93 | Nephrolithiasis (HP:0000787) | 2.38354388 |
| 94 | Hypoproteinemia (HP:0003075) | 2.38080099 |
| 95 | Hyperphosphaturia (HP:0003109) | 2.37876886 |
| 96 | Hyperammonemia (HP:0001987) | 2.36489824 |
| 97 | Encephalitis (HP:0002383) | 2.35543056 |
| 98 | Joint hemorrhage (HP:0005261) | 2.35373096 |
| 99 | Chronic sinusitis (HP:0011109) | 2.34509881 |
| 100 | Gout (HP:0001997) | 2.34247029 |
| 101 | Eczematoid dermatitis (HP:0000976) | 2.33286526 |
| 102 | Abnormal platelet volume (HP:0011876) | 2.33249440 |
| 103 | Abnormal urine phosphate concentration (HP:0012599) | 2.32698398 |
| 104 | Gastrointestinal stroma tumor (HP:0100723) | 2.30551613 |
| 105 | Reticulocytosis (HP:0001923) | 2.29867362 |
| 106 | Cerebral palsy (HP:0100021) | 2.27482728 |
| 107 | Meningitis (HP:0001287) | 2.27172846 |
| 108 | Decreased circulating renin level (HP:0003351) | 2.26557551 |
| 109 | Metabolic alkalosis (HP:0200114) | 2.26548632 |
| 110 | Bronchitis (HP:0012387) | 2.26197036 |
| 111 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.26115195 |
| 112 | Abnormality of nucleobase metabolism (HP:0010932) | 2.24550529 |
| 113 | IgA deficiency (HP:0002720) | 2.24144734 |
| 114 | Abnormality of purine metabolism (HP:0004352) | 2.23833390 |
| 115 | Protuberant abdomen (HP:0001538) | 2.23761812 |
| 116 | Pili torti (HP:0003777) | 2.22967059 |
| 117 | Wide cranial sutures (HP:0010537) | 2.21834539 |
| 118 | Pancreatitis (HP:0001733) | 2.21510412 |
| 119 | Nausea (HP:0002018) | 2.19958736 |
| 120 | Increased mean platelet volume (HP:0011877) | 2.17863668 |
| 121 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.16696816 |
| 122 | Hypotension (HP:0002615) | 2.16209695 |
| 123 | Myositis (HP:0100614) | 2.16189256 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 2.15175953 |
| 125 | Hydroxyprolinuria (HP:0003080) | 2.15175953 |
| 126 | Hyperphosphatemia (HP:0002905) | 2.13780540 |
| 127 | Vascular calcification (HP:0004934) | 2.13047627 |
| 128 | Recurrent otitis media (HP:0000403) | 2.12572441 |
| 129 | Malnutrition (HP:0004395) | 2.10521796 |
| 130 | Focal segmental glomerulosclerosis (HP:0000097) | 2.10229895 |
| 131 | Exocrine pancreatic insufficiency (HP:0001738) | 2.10186550 |
| 132 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.08514374 |
| 133 | Megaloblastic anemia (HP:0001889) | 2.07521853 |
| 134 | Abnormality of the gastric mucosa (HP:0004295) | 2.05864154 |
| 135 | Late onset (HP:0003584) | 2.05789912 |
| 136 | Hypoplasia of the thymus (HP:0000778) | 2.04618388 |
| 137 | Gastrointestinal dysmotility (HP:0002579) | 2.03861030 |
| 138 | Fatigable weakness (HP:0003473) | 2.03753629 |
| 139 | Abnormality of the neuromuscular junction (HP:0003398) | 2.03753629 |
| 140 | Abnormality of the common coagulation pathway (HP:0010990) | 2.01793058 |
| 141 | Abdominal distention (HP:0003270) | 2.00815301 |
| 142 | Metabolic acidosis (HP:0001942) | 2.00135609 |
| 143 | Recurrent abscess formation (HP:0002722) | 1.99043805 |
| 144 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.97586316 |
| 145 | Hypolipoproteinemia (HP:0010981) | 1.97463356 |
| 146 | Growth hormone excess (HP:0000845) | 1.96718175 |
| 147 | Gingival bleeding (HP:0000225) | 1.96129034 |
| 148 | Lymphoma (HP:0002665) | 1.95529482 |
| 149 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93292787 |
| 150 | Abnormality of magnesium homeostasis (HP:0004921) | 1.92779141 |
| 151 | Abnormality of oral frenula (HP:0000190) | 1.92387354 |
| 152 | Symptomatic seizures (HP:0011145) | 1.91690433 |
| 153 | Cupped ribs (HP:0000887) | 1.90430180 |
| 154 | Abnormality of renin-angiotensin system (HP:0000847) | 1.90243460 |
| 155 | Thrombocytosis (HP:0001894) | 1.89846641 |
| 156 | Rickets (HP:0002748) | 1.89103776 |
| 157 | Rectal prolapse (HP:0002035) | 1.88430239 |
| 158 | Hyperparathyroidism (HP:0000843) | 1.88091170 |
| 159 | Abnormal pancreas size (HP:0012094) | 1.87208788 |
| 160 | Abnormality of macrophages (HP:0004311) | 1.86307758 |
| 161 | Disinhibition (HP:0000734) | 1.86285932 |
| 162 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84850922 |
| 163 | Mucopolysacchariduria (HP:0008155) | 1.84850922 |
| 164 | Hyperactive renin-angiotensin system (HP:0000841) | 1.84522238 |
| 165 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84363274 |
| 166 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84196374 |
| 167 | Pigmentary retinal degeneration (HP:0001146) | 1.84132136 |
| 168 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.83322564 |
| 169 | Cellulitis (HP:0100658) | 1.81144218 |
| 170 | Amyloidosis (HP:0011034) | 1.80888744 |
| 171 | Seborrheic dermatitis (HP:0001051) | 1.80502899 |
| 172 | Gingivitis (HP:0000230) | 1.80220201 |
| 173 | Hepatitis (HP:0012115) | 1.79681910 |
| 174 | Vacuolated lymphocytes (HP:0001922) | 1.79213361 |
| 175 | Abnormality of reticulocytes (HP:0004312) | 1.77181647 |
| 176 | Osteomalacia (HP:0002749) | 1.77080465 |
| 177 | Vasculitis (HP:0002633) | 1.76441376 |
| 178 | Viral hepatitis (HP:0006562) | 1.76144485 |
| 179 | Irritability (HP:0000737) | 1.75127848 |
| 180 | Abnormal glucose tolerance (HP:0001952) | 1.74692725 |
| 181 | Joint swelling (HP:0001386) | 1.74609213 |
| 182 | Spontaneous hematomas (HP:0007420) | 1.74143061 |
| 183 | Recurrent skin infections (HP:0001581) | 1.74039599 |
| 184 | Petechiae (HP:0000967) | 1.72292183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.42923931 |
| 2 | BMPR2 | 4.23485861 |
| 3 | MST4 | 4.22269310 |
| 4 | ACVR1B | 4.19641820 |
| 5 | GRK6 | 3.51404034 |
| 6 | STK10 | 3.26641716 |
| 7 | TXK | 3.17592134 |
| 8 | ITK | 2.87203411 |
| 9 | MAP3K10 | 2.74224261 |
| 10 | LMTK2 | 2.22776300 |
| 11 | DMPK | 2.19897898 |
| 12 | ZAP70 | 2.14332003 |
| 13 | FGFR4 | 2.14036139 |
| 14 | JAK3 | 2.10675892 |
| 15 | TYK2 | 1.97957778 |
| 16 | NUAK1 | 1.83699642 |
| 17 | ERN1 | 1.72288439 |
| 18 | EEF2K | 1.71476897 |
| 19 | FRK | 1.70015558 |
| 20 | IKBKE | 1.65232133 |
| 21 | NLK | 1.57579992 |
| 22 | MAP3K1 | 1.57301137 |
| 23 | STK24 | 1.54286936 |
| 24 | PRPF4B | 1.50874196 |
| 25 | LRRK2 | 1.50291935 |
| 26 | MAPK15 | 1.49137879 |
| 27 | CSK | 1.47413823 |
| 28 | PRKG2 | 1.46611324 |
| 29 | PTK6 | 1.46561326 |
| 30 | IKBKB | 1.41928309 |
| 31 | BLK | 1.33510515 |
| 32 | TBK1 | 1.32000174 |
| 33 | JAK1 | 1.30996223 |
| 34 | TRIB3 | 1.29520189 |
| 35 | FGFR3 | 1.28864601 |
| 36 | SYK | 1.24147628 |
| 37 | TAOK1 | 1.23322839 |
| 38 | MET | 1.21435717 |
| 39 | CDC42BPA | 1.20827213 |
| 40 | LCK | 1.19829943 |
| 41 | SIK1 | 1.12966602 |
| 42 | TNIK | 1.11839782 |
| 43 | CDK12 | 1.11766208 |
| 44 | NME1 | 1.10896387 |
| 45 | STK39 | 1.06493834 |
| 46 | MAP3K11 | 1.05733218 |
| 47 | PDPK1 | 0.97631463 |
| 48 | TEC | 0.96803818 |
| 49 | PRKD2 | 0.93842159 |
| 50 | PRKCQ | 0.92534099 |
| 51 | OXSR1 | 0.91185110 |
| 52 | NME2 | 0.90503938 |
| 53 | MAP3K3 | 0.89889067 |
| 54 | PRKAA2 | 0.89851982 |
| 55 | PIM1 | 0.88020384 |
| 56 | CDK9 | 0.87211000 |
| 57 | IRAK4 | 0.86243573 |
| 58 | GSK3A | 0.86056400 |
| 59 | BTK | 0.85668714 |
| 60 | MAPK11 | 0.83472469 |
| 61 | FER | 0.83196626 |
| 62 | MELK | 0.82418007 |
| 63 | MAP3K8 | 0.82315255 |
| 64 | FGFR2 | 0.82047887 |
| 65 | MAP2K2 | 0.80016552 |
| 66 | MAP3K14 | 0.79734080 |
| 67 | MAP3K13 | 0.78746185 |
| 68 | DYRK1B | 0.78621124 |
| 69 | EPHB1 | 0.78598382 |
| 70 | CLK1 | 0.78421033 |
| 71 | CDK4 | 0.76837009 |
| 72 | TYRO3 | 0.76164067 |
| 73 | DDR2 | 0.75277661 |
| 74 | MST1R | 0.74945110 |
| 75 | DAPK2 | 0.74663744 |
| 76 | STK4 | 0.74045546 |
| 77 | PIK3CG | 0.73197771 |
| 78 | MAP3K7 | 0.71157664 |
| 79 | BMX | 0.70815731 |
| 80 | TLK1 | 0.70714683 |
| 81 | MAP3K12 | 0.70711257 |
| 82 | JAK2 | 0.67336709 |
| 83 | HCK | 0.66377226 |
| 84 | MAP2K6 | 0.66187658 |
| 85 | TGFBR2 | 0.66084659 |
| 86 | PDGFRB | 0.64008614 |
| 87 | MATK | 0.63477710 |
| 88 | PIK3CA | 0.63356282 |
| 89 | RET | 0.62266180 |
| 90 | MAPKAPK3 | 0.61926768 |
| 91 | HIPK2 | 0.61318172 |
| 92 | FLT3 | 0.60158496 |
| 93 | MARK2 | 0.60148734 |
| 94 | PRKCH | 0.59482308 |
| 95 | CHUK | 0.58178663 |
| 96 | PRKCZ | 0.58013452 |
| 97 | TESK1 | 0.57341863 |
| 98 | ERBB2 | 0.57117619 |
| 99 | TRPM7 | 0.55709316 |
| 100 | KIT | 0.54367725 |
| 101 | EPHA3 | 0.53654495 |
| 102 | YES1 | 0.53217229 |
| 103 | LYN | 0.51449721 |
| 104 | PRKACG | 0.51088668 |
| 105 | RPS6KA4 | 0.49974993 |
| 106 | EIF2AK1 | 0.49462901 |
| 107 | ALK | 0.49429118 |
| 108 | PRKCI | 0.49294953 |
| 109 | CDK6 | 0.47477639 |
| 110 | PKN2 | 0.47394339 |
| 111 | MAP3K5 | 0.46811485 |
| 112 | SIK2 | 0.46693756 |
| 113 | KSR2 | 0.44137241 |
| 114 | CSF1R | 0.43200245 |
| 115 | TAOK3 | 0.42544956 |
| 116 | MAPK7 | 0.42537551 |
| 117 | PAK4 | 0.42505014 |
| 118 | PDK1 | 0.40245685 |
| 119 | MAPK3 | 0.39554436 |
| 120 | TESK2 | 0.38834725 |
| 121 | ICK | 0.38594739 |
| 122 | SRC | 0.38277916 |
| 123 | NTRK3 | 0.38032020 |
| 124 | IRAK1 | 0.37754441 |
| 125 | MAPKAPK2 | 0.35781098 |
| 126 | INSR | 0.33528956 |
| 127 | EPHA2 | 0.33294895 |
| 128 | FGR | 0.32874687 |
| 129 | RPS6KB2 | 0.32742025 |
| 130 | RIPK4 | 0.32528634 |
| 131 | CAMKK2 | 0.32032100 |
| 132 | SCYL2 | 0.31822938 |
| 133 | PRKCA | 0.30652043 |
| 134 | SMG1 | 0.30388265 |
| 135 | AKT3 | 0.30169721 |
| 136 | TNK2 | 0.30129565 |
| 137 | KDR | 0.29410112 |
| 138 | PAK1 | 0.28603352 |
| 139 | PTK2 | 0.28443123 |
| 140 | PRKD1 | 0.26085804 |
| 141 | CDC7 | 0.25730984 |
| 142 | FYN | 0.25481365 |
| 143 | MAP3K2 | 0.25080195 |
| 144 | RIPK1 | 0.24125228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.00492753 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.11451668 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.17126841 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.11271753 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.94762759 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 2.91835082 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.82406859 |
| 8 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.59571508 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58383451 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.56011395 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.36048719 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.23698879 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23669020 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 2.22969895 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.10193166 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.09563803 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.03475142 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.97954255 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97635802 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94087181 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.91922603 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83870075 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80589178 |
| 24 | Galactose metabolism_Homo sapiens_hsa00052 | 1.79713879 |
| 25 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.78296335 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.72172227 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67362853 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.66682812 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65208979 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.60912615 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53899203 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52774816 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.48141715 |
| 34 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.47714833 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.46272403 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.45518688 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.41476032 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35822917 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.35540796 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33332703 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30456130 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29633805 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26536029 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24854925 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24219570 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22764369 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16884325 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15747432 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.15424019 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.12521523 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09246728 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04964346 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03768227 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99449055 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.98777429 |
| 56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94811646 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93705606 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 0.91812772 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91611106 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90316430 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.90251465 |
| 62 | Ribosome_Homo sapiens_hsa03010 | 0.89749184 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89662031 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.89285012 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88786309 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.87478102 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87362498 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.87089698 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85992320 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85978662 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84586603 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84468205 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82655815 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82574457 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.81561041 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.80048597 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79805221 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.77755357 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76756894 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73901002 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73517867 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72556891 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71992819 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71063513 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70205528 |
| 86 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.70173786 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69661731 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68894078 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65860255 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64848506 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.64481861 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64025829 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63838338 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63632916 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62897623 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62788011 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62492626 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61419290 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.58821737 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.58220058 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.58168518 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57509017 |
| 103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56986446 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.55866156 |
| 105 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52790639 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52761539 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52689784 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50758073 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48855167 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48566767 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.48503471 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48376534 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48191030 |
| 114 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47991838 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.47443183 |
| 116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44842994 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44803498 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44040785 |
| 119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41697772 |
| 120 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40159448 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.40082660 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.39935656 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39468615 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37931511 |
| 125 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.37727789 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37492184 |
| 127 | DNA replication_Homo sapiens_hsa03030 | 0.36916456 |
| 128 | Allograft rejection_Homo sapiens_hsa05330 | 0.36398963 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.36346841 |
| 130 | Adherens junction_Homo sapiens_hsa04520 | 0.35738297 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34984690 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34920243 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34608491 |
| 134 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.34302635 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33561388 |
| 136 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.32946487 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31430593 |
| 138 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30704227 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30436928 |
| 140 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30236966 |
| 141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30071973 |
| 142 | Insulin secretion_Homo sapiens_hsa04911 | 0.25848934 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25474382 |
| 144 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24396117 |
| 145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21514981 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19552292 |
| 147 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.17658631 |
| 148 | Renin secretion_Homo sapiens_hsa04924 | 0.16329020 |
| 149 | Carbon metabolism_Homo sapiens_hsa01200 | 0.15739749 |
| 150 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15253705 |
| 151 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.15080507 |
| 152 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.14425011 |
| 153 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.06657470 |

